These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 16143471)
1. In vivo expression of GFP transgene delivered via a replicating feline leukemia virus. Pan J; Al-Dubaib M; Liao CP; Fujino Y; Hinton DR; Hayes KA; Mathes LE; Roy-Burman P Vet Microbiol; 2005 Oct; 110(3-4):181-95. PubMed ID: 16143471 [TBL] [Abstract][Full Text] [Related]
2. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A. Chang Z; Pan J; Logg C; Kasahara N; Roy-Burman P J Virol; 2001 Sep; 75(18):8837-41. PubMed ID: 11507228 [TBL] [Abstract][Full Text] [Related]
3. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays. Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344 [TBL] [Abstract][Full Text] [Related]
4. Feline leukemia virus variants in experimentally induced thymic lymphosarcomas. Pandey R; Bechtel MK; Su Y; Ghosh AK; Hayes KA; Mathes LE; Roy-Burman P Virology; 1995 Dec; 214(2):584-92. PubMed ID: 8553560 [TBL] [Abstract][Full Text] [Related]
5. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection. Rojko JL; Hoover EA; Finn BL; Olsen RG J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of feline leukemia virus subgroup A infection by coinoculation with subgroup B. Phipps AJ; Hayes KA; Al-dubaib M; Roy-Burman P; Mathes LE Virology; 2000 Nov; 277(1):40-7. PubMed ID: 11062034 [TBL] [Abstract][Full Text] [Related]
7. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats. Gomes-Keller MA; Tandon R; Gönczi E; Meli ML; Hofmann-Lehmann R; Lutz H Vet Microbiol; 2006 Jan; 112(1):11-21. PubMed ID: 16303261 [TBL] [Abstract][Full Text] [Related]
8. Recombinant equine arteritis virus as an expression vector. de Vries AA; Glaser AL; Raamsman MJ; Rottier PJ Virology; 2001 Jun; 284(2):259-76. PubMed ID: 11384225 [TBL] [Abstract][Full Text] [Related]
9. A potential therapeutic strategy to combat leukemia virus infection. Pan J; Zhong C; Chang Z; Roy-Burman P Cancer Biol Ther; 2003; 2(1):92-9. PubMed ID: 12673127 [TBL] [Abstract][Full Text] [Related]
10. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets. Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650 [TBL] [Abstract][Full Text] [Related]
11. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats. Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224 [TBL] [Abstract][Full Text] [Related]
12. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line. Burns CC; Moser M; Banks J; Alderete JP; Overbaugh J Virology; 1996 Aug; 222(1):14-20. PubMed ID: 8806483 [TBL] [Abstract][Full Text] [Related]